Home › Adenocarcinoma of Lung
Adenocarcinoma of Lung clinical trials recruiting in the U.S.
16 studies for Adenocarcinoma of Lung are recruiting participants at sites across the United States.
Cities with the most studies
By state
Recently updated studies
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT07090499DBC-664 in Adult Patients With Solid Tumors
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT07705035RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT04105270Pre- and Post-operative TEG Indices in Patients With or Without Adenocarcinoma Undergoing Surgical Resection
RecruitingObservational studyHealthy volunteers welcome
Ages 18 to 99 · All sexes · Updated Aug 24, 2026 · NCT05517811Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
RecruitingPhase 1/2
Ages 18 to 130 · All sexes · Updated Aug 21, 2026 · NCT05797168MOv19-BBz CAR T Cells in FRa+ Cancers
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jun 18, 2026 · NCT07116057Beating Lung Cancer in Ohio Protocol in Improving Survival in Patients With Stage IV Non-Small Cell Lung Cancer
Recruiting
Ages 18 and older · All sexes · Updated Jun 17, 2026 · NCT03199651A Study of LP-300 With Carboplatin and Pemetrexed in Never Smokers With Advanced Lung Adenocarcinoma
RecruitingPhase 2
Ages 18 and older · All sexes · Updated May 4, 2026 · NCT05456256Defactinib, Avutometinib and Nivolumab for the Treatment of Anti-PD1 Refractory LKB1-Mutant Advanced Non-Small Cell Lung Cancer
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Apr 6, 2026 · NCT06495125Using Biomarkers for Diagnosis, Risk Stratification of Post -Treatment Recurrence and Long-Term Surveillance of Lung Cancer
RecruitingObservational study
Ages 18 and older · All sexes · Updated Apr 1, 2026 · NCT05665504Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
RecruitingPhase 1
Ages 18 to 75 · All sexes · Updated Mar 17, 2026 · NCT04119024Engagement of Veterans With Lung Cancer
Recruiting
Ages 18 and older · All sexes · Updated Mar 3, 2026 · NCT07219251Testing the Safety of Dapagliflozin Prior to Surgery for the Treatment of Patients With Stage IA Lung Adenocarcinoma
RecruitingEarly phase 1
Ages 22 and older · All sexes · Updated Feb 19, 2026 · NCT07235280An Investigational Scan (Me-4FDG PET/CT) for the Detection of Sodium-Glucose Transport for Early Diagnosis of Lung Cancer
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Nov 10, 2025 · NCT05558904CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Mar 10, 2023 · NCT05733000I3LUNG: Integrative Science, Intelligent Data Platform for Individualized LUNG Cancer Care With Immunotherapy
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jan 6, 2023 · NCT05537922From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.